Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuyoshi Takahashi is active.

Publication


Featured researches published by Mitsuyoshi Takahashi.


Journal of Clinical Microbiology | 2004

Mutations including IS6110 insertion in the gene encoding the MPB64 protein of Capilia TB-negative Mycobacterium tuberculosis isolates.

Kazue Hirano; Akio Aono; Mitsuyoshi Takahashi; Chiyoji Abe

ABSTRACT A simple immunochromatographic assay, Capilia TB, using anti-MPB64 monoclonal antibodies, is a kit for discriminating between the Mycobacterium tuberculosis complex and mycobacteria other than tubercle bacilli. The sensitivity of the kit was estimated to be 99.2% (381 of 384 samples). The sequencing analysis revealed that all of the Capilia TB-negative isolates had mutations within the mpb64 gene, leading to the production of an incomplete protein as a result of a deletion of the C-terminal region of the protein.


Journal of Clinical Microbiology | 2003

Heterogeneity of RNA Polymerase Gene (rpoB) Sequences of Mycobacterium gordonae Clinical Isolates Identified with a DNA Probe Kit and by Conventional Methods

Saotomo Itoh; Yuko Kazumi; Chiyoji Abe; Mitsuyoshi Takahashi

ABSTRACT In a previous study, we have evaluated genetic identification by using the rpoB gene, which was recently introduced by Kim et al. (J. Clin. Microbiol. 39:2102-2109, 2001; J. Clin. Microbiol. 37:1714-1720, 1999). In this process, we examined the rpoB gene heterogeneity of clinical isolates identified as Mycobacterium gordonae with the conventional biological and biochemical tests and/or a commercially available DNA probe kit. Sequencing of the rpoB gene of 34 clinical isolates revealed that M. gordonae clinical isolates were classified into four major clusters (A, B, C, and D). Interestingly, organisms belonging to cluster D (15 isolates) did not hybridize with M. gordonae ATCC 14470 and specifically possessed urease activity. Therefore, it could be considered to be a novel mycobacterium. The identification of M. gordonae is known to have ambiguous results sometimes. On the other hand, identification of clinical isolates seems to be inconvenient and unsuitable because of a more than 99% 16S rRNA gene similarity value between clusters. These findings suggest that the existence of M. gordonae-like mycobacteria that share similar biochemical and biological characteristics with the 16S rRNA gene of an M. gordonae type strain but less similarity at the genomic DNA level may have complicated the identification of M. gordonae in many laboratories. Furthermore, compared with hsp65 PCR restriction analysis (PRA), rpoB PRA would have the advantage of producing no ambiguous results because of the intracluster homogeneity of the rpoB gene. In this case, rpoB would provide clearer results than hsp65, even if PRA analysis was used. We demonstrated that these M. gordonae-like mycobacteria were easily distinguished by PRA of the rpoB sequence. Additionally, the significance of this M. gordonae-like cluster may help to establish the comparison between the M. gordonae isolates from a clinical specimen and an infectious process in a given patient and to determine the true incidence of infection with this microorganism.


Microbiology and Immunology | 1993

Restriction Fragment Length Polymorphism Analysis of Epidemiologically Related Mycobacterium tuberculosis Isolates

Mitsuyoshi Takahashi; Yuko Kazumi; Yutaka Fukasawa; Kazue Hirano; Toru Mori; Jeremy W. Dale; Chiyoji Abe

Restriction fragment length polymorphism (RFLP) analysis of a large number of Japanese isolates of Mycobacterium tuberculosis, containing isolates from small outbreaks of M. tuberculosis infection, and clinical isolates of M. bovis BCG, was carried out using a DNA probe derived from the insertion sequence IS986. Clinical isolates of M. tuberculosis had a high degree of RFLP. The occurrences of the IS element varied from 1 to 19, the majority of isolates having 8 to 15 copies. Very similar fingerprints, however, were seen among strains isolated in the Kanto district. In particular, 3 strains were of the same pattern with or without an additional band. Similarity of the banding patterns of strains islated in the same district was observed in other areas. Six groups of strains, each group arising from a suspected common source of infection, were analyzed. Of these, 5 showed identical fingerprints within each group, but one showed different fingerprints. RFLP patterns of three strains isolated from individuals with lymphadenitis developed about two months after BCG vaccination, and one strain isolated from a bladder cancer patient with BCG instillation therapy were identical to those of BCG‐Tokyo which had been used for the vaccination and therapy. These results confirm that RFLP analysis using IS986 is a suitable tool for epidemiology of tuberculosis.


Microbiology and Immunology | 1997

Studies of Polymorphic DNA Fingerprinting and Lipid Pattern of Mycobacterium tuberculosis Patient Isolates in Japan

Kunyaluk Chaicumpar; Nagatoshi Fujiwara; Osamu Nishimura; Hisako Hotta; Jiong Wei Pan; Mitsuyoshi Takahashi; Chiyoji Abe; Ikuya Yano

Strain differentiation by DNA restriction fragment length polymorphism (RFLP) has been used mainly for the epidemiological purpose of Mycobacterium tuberculosis infection. In this study, we tried to connect the molecular and phenotypic characteristics of M. tuberculosis patient isolates by comparing the DNA fingerprints obtained by RFLP using IS6110 and lipid patterns using two‐dimensional thin‐layer chromatography (2‐D TLC) with silica gel, since M. tuberculosis has a lipid‐rich cell envelope which contributes to the virulence and immunomodulatory properties. We found that 66 isolates of M. tuberculosis from tuberculosis patients showed that the occurrence of IS6110 varied from 1 to 24 copies. The IS6110 patterns were highly variable among isolates. Fifty different RFLP patterns were observed, and 12 RFLP patterns were shared by two or more strains. By computerized analysis of the RFLP patterns of M. tuberculosis patient isolates, we found that 95% of the isolates fell into seven clusters, from A to G, with at least two isolates in each (> 30% similarity). Among the cellular lipids, the phospholipid composition did not differ by strain, whereas the glycolipid pattern differed markedly. Especially, the relative concentration of cord factor and sulfolipid, both of which were known as virulent factors, varied by strain. The fingerprints of some strains showed an association between the DNA and glycolipid patterns, even though some of the same DNA fingerprint strains showed differences in lipid patterns. Among the patient isolates, M. tuberculosis strain 249 possessed a specific glycolipid with 2‐O‐methyl‐L‐rhamnose and L‐rhamnose, which is rarely found in other strains. This glycolipid showed serological activity against the sera of tuberculosis patients, even if the reactivity was not as strong as trehalose dimycolate. It also showed the inhibition of phagosome‐lysosome fusion in macrophages, suggesting involvement with virulence. These results suggest that RFLP analysis using IS6110 is useful for clustering the human isolates of M. tuberculosis, however, for further strain differentiation on virulence, a lipid analysis provides more information.


The Journal of Urology | 1998

TUBERCULOUS ENTERITIS AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY: A CASE OF MISTAKEN IDENTITY

Ryosuke Nemoto; Isao Nakamura; Ichiro Honjyo; Mitsuyoshi Takahashi; Chiyoji Abe

Various local and systemic complications of intravesical bacillus Calmette-Guerin (BCG) therapy have been reported since its introduction for the management of superficial bladder cancer.1 We report a case of tuberculous enteritis after intravesical BCG instillation. Restriction fragment length polymorphism analysis speciated the organism as Mycobacterium tuberculosis, proving that it was not acquired through intravesical BCG therapy. CASE REPORT


Microbiology and Immunology | 1985

Preliminary Studies of Fructan-Hydrolyzing Bacteria from Human Dental Plaque

Kenshiro Takamori; Fumiko Mizuno; Ayako Yamamoto; Yumiko Etoh; Mitsuyoshi Takahashi; Nobuyoshi Takahashi

Fructans in dental plaque contain two different types of fructopolysaccharides : one is the levan-type with (2,6)-linked ƒA-fructofuranoside residues and the other is the inulin-type with (2,1)-linked jS-fructofuranoside residues (4). Fructans formed in plaque serve as an exogenous carbohydrate source for plaque bacteria (11), and become gradually hydrolyzed by such bacteria, resulting in continued acid


Journal of Clinical Microbiology | 1993

Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test

Chiyoji Abe; Kazue Hirano; Masako Wada; Yuko Kazumi; Mitsuyoshi Takahashi; Y Fukasawa; T Yoshimura; C Miyagi; S Goto


Journal of Clinical Microbiology | 1999

Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe Assay

Kazue Hirano; Chiyoji Abe; Mitsuyoshi Takahashi


Journal of Clinical Microbiology | 1992

Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria.

Chiyoji Abe; S Hosojima; Y Fukasawa; Yuko Kazumi; Mitsuyoshi Takahashi; Kazue Hirano; Toru Mori


Kekkaku(Tuberculosis) | 2004

[Mycobacterium shinshuense isolated from cutaneous ulcer lesion of right lower extremity in a 37-year-old woman].

Yuko Kazumi; Koji Ohtomo; Mitsuyoshi Takahashi; Satoshi Mitarai; Isamu Sugawara; Junko Izumi; Akiko Andoh; Hidehiro Hasegawa

Collaboration


Dive into the Mitsuyoshi Takahashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazue Hirano

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuko Kazumi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Toru Mori

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge